Literature DB >> 6763010

The effect of uraemic "middle-sized molecules" on T lymphocyte functions.

K Kálmán, L Löcsey, M Hauck, A Leövey.   

Abstract

The activity of the leucocyte inhibitory factor (LIF) stimulated with Concanavalin A was examined in chronic uraemic, haemodialysed patients. It was found that the LIF activity decreased in chronic uraemic patients as compared with the normal controls. The absolute T lymphocyte count and active E rosette formation also decreased. In in vitro experiments the authors have also examined the inhibitory effect of the so-called "middle-sized molecule" (MSM) on uraemic materials separated from the serum and the haemofiltrate. They observed that the materials with a molecular weight of 1000-1500 isolated both from the serum and the haemofiltrate significantly inhibited the Con A stimulated LIF production of normal lymphocytes and decreased the ratio of the active E rosette-forming T lymphocytes. On the basis of their experiments the MSM uraemic materials are considered responsible for the decreased immune reactivity of uraemic patients. These uraemic toxins can be dialysed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6763010     DOI: 10.1007/bf02082475

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  22 in total

1.  Uremic middle molecules.

Authors:  J Bergström; P Fürst
Journal:  Clin Nephrol       Date:  1976-04       Impact factor: 0.975

2.  Deficiency of T and B lymphocytes in uremic subjects and partial improvement with maintenance hemodialysis.

Authors:  W E Hoy; R V Cestero; R B Freeman
Journal:  Nephron       Date:  1978       Impact factor: 2.847

Review 3.  Renal failure and infection.

Authors:  J Z Montgomerie; G M Kalmanson; L B Guze
Journal:  Medicine (Baltimore)       Date:  1968-01       Impact factor: 1.889

4.  Suppression of in vitro lymphocyte function by uremic toxins.

Authors:  J E Harris; D Pagé; G Posen; T Stewart
Journal:  J Urol       Date:  1972-08       Impact factor: 7.450

5.  White blood count in patients on regular haemodialysis.

Authors:  M Papadimitriou; L R Baker; B Seitanidis; L H Sevitt; A E Kulatilake
Journal:  Br Med J       Date:  1969-10-11

6.  Inhibition of human leukocyte migration inhibitory factor (LIF) by alpha-L-fucose.

Authors:  K Bendtzen
Journal:  Acta Allergol       Date:  1975-12

7.  Leukocyte migration inhibitory factor (LMIF) profile in primary and secondary immunodeficiency disease.

Authors:  A J Górski; B Dupont; J A Hansen; R O'Reilly; E Smithwick; R Górska; R A Good
Journal:  Clin Exp Immunol       Date:  1976-12       Impact factor: 4.330

8.  Human lymphocyte subpopulation: early and late rosettes.

Authors:  D T Yu
Journal:  J Immunol       Date:  1975-07       Impact factor: 5.422

9.  Cell-mediated immunity in patients on long-term haemodialysis.

Authors:  C A Kauffman; A D Manzler; J P Phair
Journal:  Clin Exp Immunol       Date:  1975-10       Impact factor: 4.330

10.  T-lymphocytes and serum inhibitors of cell-mediated immunity in renal insufficiency.

Authors:  J L Touraine; F Touraine; J P Revillard; J Brochier; J Traeger
Journal:  Nephron       Date:  1975       Impact factor: 2.847

View more
  1 in total

1.  Protein-Bound Uremic Toxins and Immunity.

Authors:  Maria Teresa Rocchetti; Carmela Cosola; Elena Ranieri; Loreto Gesualdo
Journal:  Methods Mol Biol       Date:  2021
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.